Your browser doesn't support javascript.
loading
Clinical utility of checkpoint inhibitors against metastatic bladder cancer: overcoming challenges to find a way forward.
Bilé-Silva, Andreia; Lopez-Beltran, Antonio; Blanca, Ana; Lopez-Rios, Fernando; Gómez-Gómez, Enrique; Cimadamore, Alessia; Montironi, Rodolfo; Vau, Nuno; Cheng, Liang.
Affiliation
  • Bilé-Silva A; Urology Department, Egas Moniz Hospital, Centro Hospitalar de Lisboa Ocidental, Lisbon, Portugal.
  • Lopez-Beltran A; Department of Morphological Sciences, Unit of Pathology, Cordoba University Medical School, Cordoba, Spain.
  • Blanca A; Urology Department, Reina Sofia University Hospital, Cordoba, Spain.
  • Lopez-Rios F; Pathology Department, 12 de Octubre University Hospital, Universidad Complutense de Madrid. Research Institute 12 de Octubre University Hospital (i+12), Madrid, Spain.
  • Gómez-Gómez E; Urology Department, Reina Sofia University Hospital, Cordoba, Spain.
  • Cimadamore A; Institute of Pathological Anatomy, Department of Medical Area (DAME), University of Udine, Udine, Italy.
  • Montironi R; Molecular Medicine and Cell Therapy Foundation, Polytechnic University of Marche, Ancona, Italy.
  • Vau N; Medical Oncology, Champalimaud Clinical Center, Lisbon, Portugal.
  • Cheng L; Department of Pathology and Laboratory Medicine, Brown University Warren Alpert Medical School, Providence, RI, USA.
Expert Opin Biol Ther ; 23(5): 407-418, 2023 05.
Article in En | MEDLINE | ID: mdl-37036223

Full text: 1 Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Carcinoma, Transitional Cell Limits: Humans Language: En Journal: Expert Opin Biol Ther Journal subject: BIOLOGIA / TERAPEUTICA Year: 2023 Type: Article Affiliation country: Portugal

Full text: 1 Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Carcinoma, Transitional Cell Limits: Humans Language: En Journal: Expert Opin Biol Ther Journal subject: BIOLOGIA / TERAPEUTICA Year: 2023 Type: Article Affiliation country: Portugal